The drug producer Fresenius Kabi is taking its first steps under a new strategy to bolster its intravenous drug offerings, starting with a $240 million acquisition of the smart infusion pump maker ...

Fresenius Kabi warned healthcare providers in a Dec. 5 letter to stop using certain Ivenix large-volume pumps because of the risk that pneumatic valves installed in some devices could issue a pump ...

For the third time since 2022, when it purchased infusion pump maker Ivenix for $240 million, Fresenius Kabi has earned a Class I rating from the FDA for a recall of the Ivenix medication delivery ...

Fresenius Kabi USA recently announced the recall of its Ivenix Infusion Pump LVP software has been identified as Class I by FDA. The Ivenix Infusion system is indicated for both hospital and ...

The early alert on Fresenius' device is part of a new pilot by the FDA to improve the timeliness around public communications over potentially high-risk device recalls. Image credit: Tada Images via ...

FDA has upgraded Fresenius Kabi’s voluntary recall of certain Ivenix Large Volume Pump (LVP) primary administration sets to Class I after the company identified a manufacturing defect that could cause ...

The U.S. FDA has announced a class I recall of Iveninx large-volume infusion pumps made by Fresenius Kabi USA of Lake Zurich, Ill., due to a mechanical issue with fluid valve pins that could cause the ...

Fresenius Kabi USA recalled 1,546 large infusion pumps in a Class I recall, the most serious type, because of a risk of leaking products entering the electrical system and shutting down the device.

U.S. authorities are warning healthcare entities of security flaws in certain Fresenius Kabi Agilia Connect Infusion Systems. U.S. government authorities have issued an advisory warning about remotely ...

Fresenius SE’s negotiations to acquire Pfizer Inc.’s pumps and devices business have stalled on valuation, according to people with knowledge of the matter. Pfizer has decided to resume talks with ...

FRANKFURT, June 6 (Reuters) - German healthcare supplier Fresenius and British engineering company Smiths Group (Other OTC: SMGKF - news) have emerged as the final bidders for Pfizer (NYSE: PFE - news ...